This website uses cookies to enhance the user experience.
||
Z

ZIMMER BIOMET NORWAY AS995 610 930

Purchase and sale
Limited company
Luhrtoppen 2 1470 LØRENSKOG, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

ZIMMER BIOMET NORWAY AS

Operating
Forskning, utvikling, produksjon og handel i medisinske implantater, korresponderende utstyr og andre medisinske innretninger samt å yte respektive tjenester. Selskapet kan på generelt grunnlag utøve annen tilknyttet eller lignende virksomhet og aktivitet.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
RE

Rune Erik Pilegård1970

Chairman of the board
JM

Jenny Madelene Stokke1983

Years since formation
16 years
since Jun 10, 2010
Type
Limited company
VAT registered
Yes
Number of employees
8

Ownership

Number of shares and share classes
1,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
161,728,235
NOK
Annual total result 2024
8,735,186
NOK
Total equity 2024
36,875,453
NOK
Last update: Jan 14, 2026

Management

Management / administration

NameRoleShares
RE

Rune Erik Pilegård

1970

Managing Director/CEO-

Board

NameRoleShares
JM

Jenny Madelene Stokke

1983

Chairman-
RE

Rune Erik Pilegård

1970

Board Member-
CL

Claire Lisa Savine

1984

Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
E
ECIT SERVICES AS
Accountant-
Last update: May 15, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
GZ

Gmbh Zimmer

Ordinary shares
1,000
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
161,728,235
157,761,383
143,477,369
142,568,169
Annual Total Result
8,735,186
6,163,572
6,442,428
6,953,285
Total assets
61,537,024
51,096,458
42,285,214
64,714,950
Total liabilities
24,661,571
22,956,192
20,308,520
23,988,549
Total equity
36,875,453
28,140,266
21,976,694
40,726,401

P&L

Year2024202320222021
Total operating income
161,728,235
157,761,383
143,477,369
142,568,169
Total operating costs
151,489,123
150,265,261
135,637,247
133,912,441
Operating result
10,239,112
7,496,122
7,840,122
8,655,728
Financial income/costs
1,083,379
511,229
528,644
337,877
Profit before tax
11,322,491
8,007,351
8,368,766
8,993,605
Total tax & extraordinary income/cost
2,587,305
1,843,779
1,926,338
2,040,320
Annual Total Result
8,735,186
6,163,572
6,442,428
6,953,285

Balance overview

Year2024202320222021
Total fixed assets
20,429,117
15,473,451
519,234
35,545,178
Total current assets
41,107,907
35,623,007
41,765,980
29,169,772
Total assets
61,537,024
51,096,458
42,285,214
64,714,950
Short term debt
24,661,571
22,956,192
20,308,520
23,988,549
Long term debt
0
0
0
0
Total liabilities
24,661,571
22,956,192
20,308,520
23,988,549
Contributed capital
9,951,693
9,951,693
9,951,693
9,951,693
Retained earnings
26,923,760
18,188,573
12,025,001
30,774,708
Total equity
36,875,453
28,140,266
21,976,694
40,726,401
Total equity and liabilities
61,537,024
51,096,458
42,285,214
64,714,950

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods